Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin Pharmaceutical Investing
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations Pharmaceutical Investing
Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery Pharmaceutical Investing
Applied UV Receives $1.5 Million Purchase Order to Provide Premium Furnishings for Luxury Resort in Orlando Medical Device Investing
Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando Medical Device Investing
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference Medical Device Investing
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their Options Pharmaceutical Investing
Medtronic ADAPT study results published in The Lancet Diabetes & Endocrinology show improved glycemic control and treatment satisfaction among those using MiniMed 780G system¹, compared to insulin injections Medical Device Investing
